These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11339435)

  • 1. Homocysteine and vascular disease.
    Hankey GJ; Eikelboom JW
    Indian Heart J; 2000; 52(7 Suppl):S18-26. PubMed ID: 11339435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and vascular disease.
    Hankey GJ; Eikelboom JW
    Lancet; 1999 Jul; 354(9176):407-13. PubMed ID: 10437885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of plasma homocysteine in vascular disease.
    Hankey GJ; Eikelboom JW; Ho WK; van Bockxmeer FM
    Med J Aust; 2004 Sep; 181(6):314-8. PubMed ID: 15377241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is plasma homocysteine a modifiable risk factor for stroke?
    Hankey GJ
    Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homocysteinemia: role in vascular disease].
    Conri C; Constans J; Parrot F; Skopinski S; Cipriano C
    Presse Med; 2000 Apr; 29(13):737-41. PubMed ID: 10797829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.
    Stehouwer DA
    Drugs Aging; 2000 Apr; 16(4):251-60. PubMed ID: 10874520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
    Kaul S; Zadeh AA; Shah PK
    J Am Coll Cardiol; 2006 Sep; 48(5):914-23. PubMed ID: 16949480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population.
    Hankey GJ; Eikelboom JW; Loh K; Tang M; Pizzi J; Thom J; Yi Q
    Cerebrovasc Dis; 2005; 19(2):110-6. PubMed ID: 15608435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
    Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
    JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine, folic acid and coronary artery disease: possible impact on prognosis and therapy.
    Djuric D; Jakovljevic V; Rasic-Markovic A; Djuric A; Stanojlovic O
    Indian J Chest Dis Allied Sci; 2008; 50(1):39-48. PubMed ID: 18610689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration.
    Collaboration HLT
    BMJ; 1998 Mar; 316(7135):894-8. PubMed ID: 9569395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine in occlusive vascular disease: a risk marker or risk factor.
    Bhargava S; Ali A; Manocha A; Kankra M; Das S; Srivastava LM
    Indian J Biochem Biophys; 2012 Dec; 49(6):414-20. PubMed ID: 23350275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
    Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
    Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine. The association with atherosclerotic vascular disease in older persons.
    Aronow WS
    Geriatrics; 2003 Sep; 58(9):22-4, 27-8. PubMed ID: 14518174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels of homocysteine and atherosclerotic vascular disease.
    Christen WG; Ridker PM
    Curr Atheroscler Rep; 2000 May; 2(3):194-9. PubMed ID: 11122744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
    Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
    J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K
    Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
    Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
    Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.